Nanang Rudianto Ariefta (Nanang R Ariefta)

Years Active: 2017-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Nanang Rudianto Ariefta, Baldorj Pagmadulam, Masaki Hatano, Noriko Ikeda, Kunio Isshiki, Kazuaki Matoba, Masayuki Igarashi, Coh-Ichi Nihei, Yoshifumi Nishikawa
Antiplasmodial Activity Evaluation of a Bestatin-Related Aminopeptidase Inhibitor, Phebestin. Antimicrobial agents and chemotherapy (2023)
Nanang Rudianto Ariefta, Baldorj Pagmadulam, Coh-Ichi Nihei, Yoshifumi Nishikawa
Sparsomycin Exhibits Potent Antiplasmodial Activity In Vitro and In Vivo. Pharmaceutics 14 (3) (2022)
Nanang Rudianto Ariefta, Muhlisun Azim, Takako Aboshi, Takuya Koseki, Yoshimasa Taniguchi, Makoto Fujita, Yoshihito Shiono
Colletofurans A-E, 1-Octyl-1,3-dihydroisobenzofuran Derivatives from Colletotrichum boninense AM-12-2. Organic letters 22 (8) (2020)
Abdou Tchoukoua, Takuma Suzuki, Nanang Rudianto Ariefta, Takuya Koseki, Yusuke Okawa, Ken-Ichi Kimura, Yoshihito Shiono
A new eremophilane sesquiterpene from the fungus Xylaria sp. V-27 and inhibition activity against degranulation in RBL-2H3 cells. The Journal of antibiotics 70 (12) (2017)
Yoshihito Shiono, Niken Istikhari Muslihah, Takuma Suzuki, Nanang Rudianto Ariefta, Chairil Anwar, Handojo Hadi Nurjanto, Takako Aboshi, Tetsuya Murayama, Keitaro Tawaraya, Takuya Koseki, Jun Yoshida, Narandulam Usukhbayar, Shota Uesugi, Ken-Ichi Kimura
New eremophilane and dichlororesorcinol derivatives produced by endophytes isolated from Ficus ampelas. The Journal of antibiotics 70 (12) (2017)

Nanang Rudianto Ariefta.css-eqlu8i{font-size:small;padding-left:4px;} (Nanang R Ariefta)